Lavipharm S.A. (ATH:LAVI)

Lavipharm Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.17	5.59	8.44	18.24	1.64	1.93
Short-Term Investments	-	-	-	-	0	0.02
Trading Asset Securities	-	-	0	0	-	-
Cash & Short-Term Investments	6.17	5.59	8.44	18.24	1.64	1.95
Cash Growth	-29.01%	-33.76%	-53.75%	1013.12%	-15.99%	9.92%
Accounts Receivable	15.19	12.42	12.17	8.68	7.58	8.17
Other Receivables	3.9	3.72	2.85	5.2	5.33	2.47
Receivables	19.09	16.14	16.57	15.43	14.45	12.2
Inventory	21.32	20.49	16.21	10.44	9.24	8.42
Prepaid Expenses	-	0.86	1.38	-	-	-
Other Current Assets	1.66	1.92	3.06	1.49	0.64	0.77
Total Current Assets	48.25	45	45.65	45.6	25.96	23.34
Property, Plant & Equipment	21.32	21.36	19.54	17.06	17.46	17.05
Long-Term Investments	0.2	0	1.05	0.52	-	-
Other Intangible Assets	43.5	45.18	41.04	44.02	1.31	1.53
Long-Term Deferred Tax Assets	5.7	6.55	1.25	2.37	3.06	4.2
Long-Term Deferred Charges	5.43	4.5	3.5	2.18	1.83	1.33
Other Long-Term Assets	2.26	2.9	2.75	2.42	3.12	3.04
Total Assets	126.65	125.48	114.79	114.17	52.74	50.5
Accounts Payable	5.76	7.26	8.03	6.3	4.16	2.74
Accrued Expenses	1.59	2.81	3.06	6.65	4.46	8
Short-Term Debt	7.8	9.24	6.59	21.71	21.4	1.24
Current Portion of Long-Term Debt	1.42	1.43	1.51	-	-	2.01
Current Portion of Leases	1.29	0.91	0.68	0.52	0.66	0.68
Current Income Taxes Payable	0.97	0.25	0.24	0.51	0.1	0.14
Current Unearned Revenue	0.4	0.47	0.51	0.42	0.42	0.5
Other Current Liabilities	18.42	16.77	15.17	9.63	9.87	3.49
Total Current Liabilities	37.65	39.13	35.8	45.74	41.07	18.8
Long-Term Debt	12.18	12.17	12.7	3.96	4	23.96
Long-Term Leases	11.12	10.17	11	10.99	11.28	11.53
Other Long-Term Liabilities	8.66	10.1	11.44	12.23	5.25	6.78
Total Liabilities	70.57	72.52	72.02	73.86	62.68	62.14
Common Stock	50.61	50.61	50.36	50.36	51.08	51.08
Additional Paid-In Capital	7.17	7.17	7.41	7.41	84.42	84.42
Retained Earnings	-18.72	-21.35	-30.24	-32.11	-159.96	-161.68
Comprehensive Income & Other	17.03	16.56	15.21	14.62	14.48	14.51
Total Common Equity	56.08	52.98	42.74	40.28	-9.98	-11.68
Minority Interest	-0.01	-0.01	0.03	0.04	0.04	0.03
Shareholders' Equity	56.08	52.97	42.77	40.31	-9.94	-11.64
Total Liabilities & Equity	126.65	125.48	114.79	114.17	52.74	50.5
Total Debt	33.81	33.92	32.48	37.18	37.33	39.42
Net Cash (Debt)	-27.64	-28.34	-24.04	-18.93	-35.69	-37.47
Net Cash Per Share	-0.16	-0.17	-0.14	-0.88	-2.10	-2.20
Filing Date Shares Outstanding	168.69	168.69	167.87	167.87	17.03	17.03
Total Common Shares Outstanding	168.69	168.69	167.87	167.87	17.03	17.03
Working Capital	10.6	5.88	9.85	-0.14	-15.11	4.54
Book Value Per Share	0.33	0.31	0.25	0.24	-0.59	-0.69
Tangible Book Value	12.59	7.79	1.69	-3.74	-11.29	-13.21
Tangible Book Value Per Share	0.07	0.05	0.01	-0.02	-0.66	-0.78
Land	-	1.93	1.93	1.93	1.93	9.43
Buildings	-	2.72	1.74	1.53	1.49	8.07
Machinery	-	21.45	21.14	19.31	19.09	18.31

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.